What Happened

Boston Children’s Hospital achieved a medical breakthrough by creating precise digital replicas of patients’ hearts before surgery. The process begins with standard MRI and CT scans, which are then converted into 3D models. Engineers use advanced physics simulations to bring these models to life, creating virtual twins that accurately reproduce each patient’s unique cardiac anatomy and physiology.

The technology emerged from an unexpected collaboration between Dassault Systèmes, a French aerospace company known for designing fighter jets and Formula One cars, and medical researchers. By 2019, their Living Heart Project had developed sophisticated enough simulations to guide real surgical decisions.

In the Boston case, the virtual twin revealed how the child’s heart would respond to different surgical approaches. The patient had a complex congenital defect with large holes between heart chambers, causing dangerous blood mixing. Surgeons could test various repair strategies virtually, identifying the optimal approach before entering the operating room.

Why It Matters

This technology represents a fundamental shift from one-size-fits-all medicine to truly personalized treatment. Traditional surgical planning relies on general anatomical knowledge and surgeon experience. Virtual twins provide patient-specific insights that can mean the difference between success and failure in complex cases.

The impact extends beyond individual procedures. Each virtual twin generates data that improves understanding of cardiac mechanics, potentially accelerating medical device development and drug testing. Rather than relying solely on animal models or limited human trials, researchers can now test treatments on thousands of virtual patients with different conditions.

For patients with rare conditions, this technology offers particular hope. When surgeons encounter uncommon anatomical variations, virtual twins provide a safe testing ground for innovative approaches that might otherwise be too risky to attempt.

Background

The Living Heart Project launched in 2014 as an ambitious attempt to create the world’s first complete virtual heart. Dassault Systèmes partnered with Stanford University, bringing together expertise in computational fluid dynamics originally developed for aerospace applications.

The aerospace connection proves crucial—simulating blood flow through heart chambers requires the same mathematical principles used to model airflow over aircraft wings. Both involve complex fluid dynamics, pressure differentials, and structural mechanics under varying conditions.

Early versions focused on healthy hearts, but researchers quickly realized the greater potential lay in modeling diseased and abnormal hearts. Each pathological condition presents unique challenges that generic models cannot address. The team expanded to include cardiac surgeons, biomedical engineers, and regulatory experts from multiple institutions.

By 2018, the technology had advanced sufficiently for clinical application. The first surgical planning cases demonstrated that virtual twins could predict real-world outcomes with remarkable accuracy. Surgeons reported increased confidence and improved patient outcomes when using virtual twin guidance.

What’s Next

The technology is rapidly expanding beyond surgical planning. Researchers envision virtual twins accompanying patients throughout their lives, continuously updated with new medical data. These “digital health companions” could predict heart attacks days in advance or optimize medication dosing in real-time.

Current development focuses on making virtual twins faster and more accessible. While early models required weeks to create, newer automated systems can generate basic virtual twins in hours. Cloud computing platforms are making the technology available to smaller hospitals without specialized engineering teams.

The FDA has begun developing regulatory frameworks for virtual twin applications, recognizing their potential to transform medical device testing and drug development. Clinical trials using virtual twins as primary endpoints could reduce costs and timeline significantly.

Longer-term possibilities include virtual twins for other organs. Brain, liver, and lung models are in development, each presenting unique modeling challenges. The ultimate goal: comprehensive virtual humans that could revolutionize how we understand, diagnose, and treat disease.

Key Takeaways

• Virtual heart twins created from medical scans have guided over 2,000 successful cardiac surgeries worldwide
• The technology allows surgeons to practice patient-specific procedures virtually before operating
• Aerospace simulation expertise originally used for fighter jets now powers medical virtual twins
• Each virtual twin provides unique insights impossible to obtain from traditional medical imaging
• Future applications could include lifelong digital health companions that predict medical emergencies
• The technology promises to accelerate medical device development and drug testing through virtual trials